Document Detail


Thrombogenicity of various endovascular stent types: an in vitro evaluation.
MedLine Citation:
PMID:  12397125     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The aim of this study was to evaluate the thrombogenicity of different peripheral stent types in a standardized in vitro model with fresh human whole blood. MATERIALS AND METHODS: Different stents (N = 77; n = 7 of each of 11 types) were implanted in polyvinyl chloride tubing loops and filled with donor blood samples. After 120 minutes of blood circulation, the thrombin-antithrombin III complex (TAT) levels, beta-thromboglobulin (beta-TG) levels, and platelet counts were assessed. RESULTS: After 2 hours, significant differences were seen. TAT values (+/- SD) with the investigated stents were 31 micro g/mL +/- 20 (control, no stent), 328 micro g/mL +/- 206 (Saxx stent, peripheral medium CrNi31 L), 651 micro g/mL +/- 760 (Palmaz Corinthian Stent, 316 L stainless steel, electropolished), 1,609 micro g/mL +/- 1,264 (Palmaz Corinthian Stent, 316 L stainless steel, not electropolished), 810 micro g/mL +/- 578 (Palmaz Schatz long medium stent), 569 micro g/mL +/- 347 (Smart Nitinol stent), 1,037 micro g/mL +/- 577 (Megalink peripheral stent), 543 micro g/mL +/- 487 (peripheral stent, electropolished), 1,674 micro g/mL +/- 2,057 (peripheral stent, not electropolished), 3,128 micro g/mL +/- 1,812 (SelfX Nitinol stent, polished), 5,897 micro g/mL +/- 2,380 (SelfX Nitinol stent, unpolished), and 1,458 micro g/mL +/- 887 (bridge stent). The platelet count (x1,000/ micro L +/- SD) was 218 +/- 35 (control, no stent), 188 +/- 22 (Saxx stent), 187 +/- 20 (Palmaz Corinthian stent, electropolished), 135 +/- 37 (Palmaz Corinthian stent, not electropolished), 170 +/- 24 (Palmaz Schatz stent), 180 +/- 36 (Smart Nitinol stent), 159 +/- 26 (Megalink peripheral stent), 173 +/- 17 (peripheral stent, electropolished), 133 +/- 51 (peripheral stent, not electropolished), 123 +/- 37 (SelfX Nitinol stent, polished), 52 +/- 27 (SelfX Nitinol stent, unpolished), and 130 +/- 31 (bridge stent). CONCLUSION: This standardized study showed a wide range of platelet activation after stent implantation. Electropolishing clearly reduced the thrombogenicity of the stents.
Authors:
Gunnar Tepe; Hans P Wendel; Sascha Khorchidi; Jörg Schmehl; Jakub Wiskirchen; Benjamin Pusich; Claus D Claussen; Stephan H Duda
Related Documents :
15696295 - Fibrinogen and aer are major independent predictors of 11-year cardiovascular mortality...
12213355 - Prospective study of autonomic neuropathy as a predictor of mortality in patients with ...
15977265 - Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and non...
2386415 - Effects of pentachlorophenol and other chemical preservatives on the health of wood-tre...
16704885 - Predictors of glycemic control on insulin pump therapy in children and adolescents with...
9712335 - Changes in the aortic endothelium and plasma von willebrand factor levels during the on...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article    
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  13     ISSN:  1051-0443     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-10-24     Completed Date:  2003-01-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1029-35     Citation Subset:  IM    
Affiliation:
Department of Diagnostic Radiology, University of Tübingen, Hoppe-Seyler. Str. 3, 72076 Tübingen, Germany. gunnar.tepe@med.uni-tuebingen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alloys
Antithrombin III
Humans
Microscopy, Electron, Scanning
Peptide Hydrolases / blood
Platelet Activation
Platelet Count
Stainless Steel
Stents / adverse effects*
Surface Properties
Thrombosis / etiology*
beta-Thromboglobulin / analysis
Chemical
Reg. No./Substance:
0/Alloys; 0/antithrombin III-protease complex; 0/beta-Thromboglobulin; 12597-68-1/Stainless Steel; 52013-44-2/nitinol; 9000-94-6/Antithrombin III; EC 3.4.-/Peptide Hydrolases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of MS-325- and gadodiamide-enhanced MR venography of iliocaval veins.
Next Document:  Treatment of acute thoracic aortic injury with commercially available abdominal aortic stent-grafts.